These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37160359)

  • 1. Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and
    Singh J; Fitzgerald DA; Jaffe A; Hunt S; Barr JJ; Iredell J; Selvadurai H
    BMJ Open Respir Res; 2023 May; 10(1):. PubMed ID: 37160359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004197. PubMed ID: 28440853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous or oral antibiotic treatment in adults and children with cystic fibrosis and Pseudomonas aeruginosa infection: the TORPEDO-CF RCT.
    Langton Hewer SC; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Sutton L; Clayton D; Arch B; Tanajewski Ł; Berdunov V; Williamson PR
    Health Technol Assess; 2021 Nov; 25(65):1-128. PubMed ID: 34806975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smith S; Rowbotham NJ; Yule A; Smyth AR
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD004197. PubMed ID: 37268599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and tolerability of bronchoscopic and nebulised administration of bacteriophage.
    Singh J; Lynch S; Iredell J; Selvadurai H
    Virus Res; 2024 Oct; 348():199442. PubMed ID: 39074617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrolide antibiotics (including azithromycin) for cystic fibrosis.
    Southern KW; Solis-Moya A; Kurz D; Smith S
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD002203. PubMed ID: 38411248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
    ; ;
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Apr; 46(4):352-372. PubMed ID: 36990700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A systematic review on the use of bacteriophage in treating Staphylococcus aureus and Pseudomonas aeruginosa infections in cystic fibrosis.
    Singh J; Yeoh E; Fitzgerald DA; Selvadurai H
    Paediatr Respir Rev; 2023 Dec; 48():3-9. PubMed ID: 37598024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchoscopy-guided antimicrobial therapy for cystic fibrosis.
    Jain K; Wainwright CE; Smyth AR
    Cochrane Database Syst Rev; 2024 May; 5(5):CD009530. PubMed ID: 38700027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.
    Hewer SCL; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Williamson PR;
    Lancet Respir Med; 2020 Oct; 8(10):975-986. PubMed ID: 33007285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
    Langton Hewer SC; Smyth AR
    Cochrane Database Syst Rev; 2009 Oct; (4):CD004197. PubMed ID: 19821321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colistimethate sodium powder and tobramycin powder for inhalation for the treatment of chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: systematic review and economic model.
    Tappenden P; Harnan S; Uttley L; Mildred M; Carroll C; Cantrell A
    Health Technol Assess; 2013 Dec; 17(56):v-xvii, 1-181. PubMed ID: 24290164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nebulised anti-pseudomonal antibiotics for cystic fibrosis.
    Ryan G; Mukhopadhyay S; Singh M
    Cochrane Database Syst Rev; 2003; (3):CD001021. PubMed ID: 12917897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.
    Lo DK; Muhlebach MS; Smyth AR
    Cochrane Database Syst Rev; 2022 Dec; 12(12):CD009650. PubMed ID: 36511181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa antibiotic resistance in Australian cystic fibrosis centres.
    Smith DJ; Ramsay KA; Yerkovich ST; Reid DW; Wainwright CE; Grimwood K; Bell SC; Kidd TJ
    Respirology; 2016 Feb; 21(2):329-37. PubMed ID: 26711802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulised anti-pseudomonal antibiotics for cystic fibrosis.
    Ryan G; Mukhopadhyay S; Singh M
    Cochrane Database Syst Rev; 2000; (2):CD001021. PubMed ID: 10796732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.
    Wainwright CE; Vidmar S; Armstrong DS; Byrnes CA; Carlin JB; Cheney J; Cooper PJ; Grimwood K; Moodie M; Robertson CF; Tiddens HA;
    JAMA; 2011 Jul; 306(2):163-71. PubMed ID: 21750293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic anti-staphylococcal antibiotics for cystic fibrosis.
    Rosenfeld M; Rayner O; Smyth AR
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD001912. PubMed ID: 32997797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.